Sort
23,748 grants matching “melanoma”
Drug-Loaded Nanobubbles for Ultrasound Enhanced Delivery to Colon Cancer Liver Metastasis
$378,024Agata A Exner · Case Western Reserve University · R01 · FY2020 · EB
Project 3: Localized microneedle-directed combination immunotherapy for cSCC
$378,023Louis D Falo · University Of Pittsburgh At Pittsburgh · P50 · FY2022 · CA
Project 2: Immunotherapy with CMP-001 intratumoral and nivolumab in melanoma
$378,023Hassane M Zarour · University Of Pittsburgh At Pittsburgh · P50 · FY2022 · CA
Project 1: Evaluating the synergy of LAG3 and PD-1 in melanoma patients
$378,022Dario Aa Vignali · University Of Pittsburgh At Pittsburgh · P50 · FY2022 · CA
The B7x pathways in the tumor microenvironment
$378,000Xingxing Zang · Albert Einstein College Of Medicine · R01 · FY2024 · CA
Enhancing mitochondrial metabolism to improve anti-tumor CD8 immune response
$377,999Mercedes R. Rincon · University Of Colorado Denver · R01 · FY2022 · CA
Enhancing mitochondrial metabolism to improve anti-tumor CD8 immune response
$377,999Mercedes R. Rincon · University Of Colorado Denver · R01 · FY2025 · CA
Novel Methods for Identifying Genetic Interactions for Cancer Prognosis
$377,922Shuangge Ma · Yale University · R01 · FY2024 · CA
Genetics of latent zebrafish melanoblasts
$377,841Stephen L Johnson · Washington University · R01 · FY2006 · GM
Microcirculation of Uveal Melanoma
$377,739Robert Folberg · University Of Illinois At Chicago · R01 · FY2007 · EY
Quality and location of presented Ag as determinants of tumor-specific immunity
$377,734Victor H. Engelhard · University Of Virginia · R01 · FY2010 · CA
Therapeutic Targeting of Receptor Tyrosine Kinase Hierarchies in Schwann Cell Neoplasms
$377,725Steven L Carroll · Medical University Of South Carolina · R01 · FY2022 · NS
Therapeutic Targeting of Receptor Tyrosine Kinase Hierarchies in Schwann Cell Neoplasms
$377,725Steven L Carroll · Medical University Of South Carolina · R01 · FY2023 · NS
Autoimmune vitiligo and tolerance in the immune response to a melanoma antigen
$377,720Victor H. Engelhard · University Of Virginia · R01 · FY2007 · AI
Project 1: Murine Modeling of Tumor-Mediated Immunosuppression
$377,697Edgar G. Engleman · Stanford University · U54 · FY2020 · CA
Role of exosomal SPHK1 in ovarian cancer progression
$377,679Sunila Pradeep · Medical College Of Wisconsin · R01 · FY2022 · CA
Resolving Spatiotemporal Dynamics of Recombinant Poliovirus Immunotherapy
$377,656Matthias Gromeier · Duke University · R01 · FY2023 · CA
Quality and location of presented Ag as determinants of tumor-specific immunity
$377,646Victor H. Engelhard · University Of Virginia · R01 · FY2009 · CA
EXPERIMENTAL TRANSFORMATION OF HUMAN MELANOCYTES IN VIVO
$377,593Wistar Institute · R01 · FY2002 · CA
Development and Mechanistic Studies of an Engineered Human Enzyme to Abrogate Immune Suppression due to Elevated Methylthioadenosine (MTA) by MTAP null/low Tumors
$377,573Everett Stone · University Of Texas At Austin · R01 · FY2020 · CA
Role of Tetraspan Glycoproteins (CD63) in HIV Replication
$377,500Monique Regail Ferguson · University Of Texas Med Br Galveston · R01 · FY2011 · HL
Role of Tetraspan Glycoproteins (CD63) in HIV Replication
$377,500Monique Regail Ferguson · University Of Texas Med Br Galveston · R01 · FY2010 · HL
Role of Tetraspan Glycoproteins (CD63) in HIV Replication
$377,500Monique Regail Ferguson · University Of Texas Med Br Galveston · R01 · FY2008 · HL
Role of Tetraspan Glycoproteins (CD63) in HIV Replication
$377,500Monique Regail Ferguson · University Of Texas Med Br Galveston · R01 · FY2009 · HL
Administrative Core
$377,458James R. Heath · Institute For Systems Biology · U54 · FY2024 · CA